AU2001274601A1 - Preventives or remedies for heart failure - Google Patents

Preventives or remedies for heart failure

Info

Publication number
AU2001274601A1
AU2001274601A1 AU2001274601A AU7460101A AU2001274601A1 AU 2001274601 A1 AU2001274601 A1 AU 2001274601A1 AU 2001274601 A AU2001274601 A AU 2001274601A AU 7460101 A AU7460101 A AU 7460101A AU 2001274601 A1 AU2001274601 A1 AU 2001274601A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
heart failure
heart
failure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274601A
Inventor
Takahiko Murata
Tadashi Ohyama
Haruyoshi Ueo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Publication of AU2001274601A1 publication Critical patent/AU2001274601A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
AU2001274601A 2000-06-23 2001-06-25 Preventives or remedies for heart failure Abandoned AU2001274601A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000189175 2000-06-23
JP2000-189175 2000-06-23
PCT/JP2001/005391 WO2001097831A1 (en) 2000-06-23 2001-06-25 Preventives or remedies for heart failure

Publications (1)

Publication Number Publication Date
AU2001274601A1 true AU2001274601A1 (en) 2002-01-02

Family

ID=18688837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274601A Abandoned AU2001274601A1 (en) 2000-06-23 2001-06-25 Preventives or remedies for heart failure

Country Status (5)

Country Link
US (1) US6878689B2 (en)
EP (1) EP1297839A4 (en)
AU (1) AU2001274601A1 (en)
CA (1) CA2413252A1 (en)
WO (1) WO2001097831A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3498041B2 (en) * 2000-05-29 2004-02-16 科研製薬株式会社 Nasal formulation containing pralmorelin
WO2004014412A1 (en) * 2002-08-09 2004-02-19 Kaken Pharmaceutical Co., Ltd. Myocardial cell protecting agents
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
CA2677399C (en) 2007-02-09 2016-09-13 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same
CA2737040C (en) 2008-09-19 2017-05-02 Nektar Therapeutics Polymer conjugates of therapeutic peptides
GB201918853D0 (en) 2019-12-19 2020-02-05 Lund Lars H Methods of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1045619A (en) 1996-07-31 1998-02-17 Kaken Pharmaceut Co Ltd Oral preparation containing growth hormone secretomotor peptide
SE9703929D0 (en) 1996-11-22 1997-10-28 Pharmacia & Upjohn Ab Therapeutic use and method
ZA987383B (en) 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
US5932548A (en) * 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease

Also Published As

Publication number Publication date
US20040014671A1 (en) 2004-01-22
WO2001097831A1 (en) 2001-12-27
CA2413252A1 (en) 2002-12-20
EP1297839A1 (en) 2003-04-02
US6878689B2 (en) 2005-04-12
EP1297839A4 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
AU2001284483A1 (en) Remedies for heart failure
HUP0301729A3 (en) Remedies for heart failure
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2741801A (en) Splittable medical valve
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU2002356967A1 (en) Catheter
AU2002332083A1 (en) Guide-in-guide catheter system
AU2001280598A1 (en) Anti-occlusion catheter
AU3837300A (en) Remedies
AU2000277330A1 (en) Catheter system
AU3987800A (en) Preventives/remedies for angiostenosis
AU2001274601A1 (en) Preventives or remedies for heart failure
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2002222676A1 (en) Preventives or remedies for endometriosis
IL141402A0 (en) Preventives/remedies for multiple organ failure
AU2001236006A1 (en) Preventives/remedies for kidney diseases
AU2002249947A1 (en) Inhibition of protein-phosphatases for the treatment of heart failure
AU2001295952A1 (en) Novel remedies or preventives for angiostenosis
AU2003236039A1 (en) Preventives/remedies for hotflash
AU2001275964A1 (en) Expiration date system
AU2461200A (en) Remedies
AU7686900A (en) Preventives or remedies for arrhythmia
AU2001271026A1 (en) Remedies for bone diseases
AU2002349537A1 (en) Remedies for heart failure